EUVIMEDEUVIMED entdecken
Crossref

Sacral Neuromodulation in Non‐Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety

Mutlu Deger iD, Sumeyye Seday Kolkiran iD, Naside Mangir iD, Omer Gulpinar iD, Gokhan Temeltas, Ahmet Ozgur Guctas iD, Ersin Koseoglu iD, Batuhan Demir iD, Araz Musaev iD, Tufan Tarcan iD

Neurourology and Urodynamics · 05.08.2026

DOI: 10.1002/nau.70401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 05.08.2026. Verfasst von Mutlu Deger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Cukurova University, Adana, Turkey. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study is to evaluate the effectiveness of sacral neuromodulation (SNM) on clinical symptoms, lower urinary tract function, and objective measurements in patients diagnosed with overactive bladder (OAB) and chronic nonobstructive urinary retention (CNOUR), and to identify factors affecting treatment response. Materials and Methods This multicenter retrospective chart review included patients diagnosed with OAB and CNOUR who underwent SNM between 2015 and 2025 at four tertiary referral centers. All patients underwent a standard two‐stage SNM protocol. Clinical evaluation was performed at the first and third postoperative months after stage II implantation using urinary incontinence status, clean intermittent catheterization (CIC) requirement, bladder diary data, and uroflowmetric parameters. Demographic and technical factors affecting success were analyzed.

Results

A total of 160 patients were included in the study. Of these patients, 113 (70.6%) were female, and the mean age was 41 years. SNM was performed for OAB in 63 patients (39.4%) and for CNOUR in 97 patients (60.6%). After the first stage of SNM, clinical success was achieved in 50 patients (79.4%) in the OAB group and 68 patients (70.1%) in the CNOUR group. In the CNOUR group, the need for CIC completely disappeared in 38.2% of patients after SNM, while the frequency of catheterization decreased by at least 50% in 22.1% of patients. Urinary incontinence completely resolved in 52% of the OAB group and 69.1% of the CNOUR group. In uroflowmetric evaluation, Qmax and PVR improved significantly in the CNOUR group, whereas voided volume was used as a supportive parameter for interpreting Qmax. A higher number of contacts receiving stimulation during the first stage was significantly associated with treatment success. No serious perioperative complications were observed.

Conclusion

Sacral neuromodulation is an effective and safe treatment option for patients with overactive bladder and chronic urinary retention. Its ability to reduce the need for catheterization and improve voiding function is of great clinical importance, especially in patients with chronic urinary retention. The success of SNM can be increased with appropriate patient selection, careful evaluation during the testing phase, and optimal technical application.

Schlagwörter

Stichwörter der Autor:innen

chronic nonobstructive urinary retentionlower urinary tract symptomsoveractive bladdersacral neuromodulation

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medicine, Cukurova University, Adana, Turkey.
  • Department of Urology, Kahramanmaraş State Hospital, Kahramanmaraş, Turkey.
  • Department of Urology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Department of Urology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Department of Urology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey.
  • Department of Urology, Marmara Pendik Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Mutlu Deger, Sumeyye Seday Kolkiran, Naside Mangir, Omer Gulpinar, Ahmet Ozgur Guctas, Ersin Koseoglu, Batuhan Demir, Araz Musaev, Tufan Tarcan

Zitieren

APA

Deger, M., Kolkiran, S. S., Mangir, N., Gulpinar, O., Temeltas, G., Guctas, A. O., Koseoglu, E., Demir, B., Musaev, A., & Tarcan, T. (2026). Sacral Neuromodulation in Non‐Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70401

Vancouver

Deger M, Kolkiran SS, Mangir N, Gulpinar O, Temeltas G, Guctas AO, et al. Sacral Neuromodulation in Non‐Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70401

BibTeX
@article{Deger2026,
  author = {Deger, Mutlu and Kolkiran, Sumeyye Seday and Mangir, Naside and Gulpinar, Omer and Temeltas, Gokhan and Guctas, Ahmet Ozgur and Koseoglu, Ersin and Demir, Batuhan and Musaev, Araz and Tarcan, Tufan},
  title = {Sacral Neuromodulation in Non‐Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70401}
}
Kostenlos starten →